AHPhA, AAHP "Correct" SmithKline "Misstatements" About Homeopathy
This article was originally published in The Tan Sheet
Executive Summary
SmithKline Beecham's Feb. 10 citizen petition seeking FDA regulatory action against the homeopathic product CigArrest contains mistaken notions about homeopathy and the way it is regulated, two homeopathic trade groups say. The American Homeopathic Pharmaceutical Association and the American Association of Homeopathic Pharmacists submitted comments on the citizen petition to FDA Nov. 11.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning